About
Apim Therapeutics is a clinical-stage oncology company developing first-in-class peptide therapeutics that target PCNA-dependent stress responses to overcome cancer treatment resistance.
Explore Apim Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.